Last October, it sold a $3.3 billion stake in the maker of Sensodyne, while GSK sold its entire stake in May. J.P. Morgan and Morgan Stanley are joint global coordinators and joint bookrunners for ...

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK (GSK.L), opens new tab and Pfizer's consumer healthcare businesses in 2019. It was spun off from ...

GlaxoSmithKline's consumer health business ... The name of the unit – whose brands include Sensodyne toothpaste and Voltaren and Panadol painkillers and Centrum multivitamins – comes from ...

Haleon, recognized for brands like Sensodyne and Advil, emerged from a merger between Pfizer’s and GSK Plc’s (NYSE:GSK) consumer healthcare divisions in 2019, with Pfizer holding a significant ...

We created Sensitivity-Free Food, a world-first launch of unique food products for Sensodyne. Partnering with a chef specialised in molecular gastronomy, three popular foods that spark sensitivity ...

GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...

Sensodyne is the market leader in toothpaste for sensitive teeth. The challenge for GSK is that customers switch to more cosmetic brands when sensitivity passes, even though high-abrasive whitening ...

The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...